We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
John Wiley & Sons Class A
WLY
$2.66B
| $12.2M | 0.03% |
191,192
-6,241
| -3% | -$405K |
|
352
Keysight
KEYS
$58.3B
| $11.9M | 0.03% |
+228,037
| New | +$10.9M |
|
|
SEE
353
DELISTED
Sealed Air
SEE
| $11.9M | 0.03% |
279,051
-244,788
| -47% | -$11.1M |
|
354
Federal Agricultural Mortgage
AGM
$2.56B
| $11.8M | 0.03% |
135,385
+1,381
| +1% | +$112K |
|
|
AMWD
355
DELISTED
American Woodmark
AMWD
| $11.7M | 0.02% |
119,197
+33,654
| +39% | +$4.21M |
|
356
HDFC Bank
HDB
$121B
| $11.6M | 0.02% |
471,372
+28,720
| +6% | +$724K |
|
357
Vulcan Materials
VMC
$36.9B
| $11.6M | 0.02% |
101,557
-14,828
| -13% | -$1.87M |
|
358
Huntsman Corp
HUN
$1.77B
| $11.4M | 0.02% |
390,187
-5,454
| -1% | -$179K |
|
|
JAG
359
DELISTED
Jagged Peak Energy Inc.
JAG
| $11.4M | 0.02% |
806,529
-8,619
| -1% | -$114K |
|
|
NATI
360
DELISTED
National Instruments Corp
NATI
| $11.4M | 0.02% |
224,843
-4,024
| -2% | -$196K |
|
361
First Financial Bankshares
FFIN
$4.97B
| $11.4M | 0.02% |
490,638
-41,190
| -8% | -$967K |
|
|
MON
362
DELISTED
Monsanto Co
MON
| $11.3M | 0.02% |
97,059
-44,561
| -31% | -$5.36M |
|
|
SAFE
363
Safehold
SAFE
$1.15B
| $11.2M | 0.02% |
226,960
+22,185
| +11% | +$1.13M |
|
364
Amphenol
APH
$209B
| $11.2M | 0.02% |
520,500
-369,804
| -42% | -$8.33M |
|
|
VSM
365
DELISTED
Versum Materials, Inc.
VSM
| $11.2M | 0.02% |
296,915
-54,732
| -16% | -$2.08M |
|
|
CIVI
366
DELISTED
Civitas Resources
CIVI
| $11M | 0.02% |
398,073
-8,834
| -2% | -$243K |
|
367
Veeva Systems
VEEV
$37.4B
| $11M | 0.02% |
150,666
-2,697
| -2% | -$174K |
|
|
GTT
368
DELISTED
GTT Communications, Inc.
GTT
| $11M | 0.02% |
193,220
-36,207
| -16% | -$1.79M |
|
369
Commault Systems
CVLT
$5.61B
| $10.8M | 0.02% |
189,202
-354,909
| -65% | -$19.1M |
|
370
Lamb Weston
LW
$7.19B
| $10.8M | 0.02% |
184,721
-34,800
| -16% | -$1.97M |
|
371
PUT
Comcast
CMCSA
$90B
| $10.7M | 0.02% |
+312,300
| New | +$12.1M |
|
|
GCP
372
DELISTED
GCP Applied Technologies Inc.
GCP
| $10.6M | 0.02% |
363,835
-71,709
| -16% | -$2.31M |
|
373
Reliance Steel & Aluminium
RS
$21.6B
| $10.6M | 0.02% |
123,217
-24,042
| -16% | -$2.15M |
|
|
HOLX
374
DELISTED
Hologic
HOLX
| $10.6M | 0.02% |
282,580
-56,806
| -17% | -$2.3M |
|
375
Alamo Group
ALG
$2.05B
| $10.5M | 0.02% |
95,708
+2,451
| +3% | +$277K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.